Skip to main content
. Author manuscript; available in PMC: 2023 Aug 2.
Published in final edited form as: Stat Biopharm Res. 2022 Aug 2;14(3):270–282. doi: 10.1080/19466315.2022.2081602

Figure 4.

Figure 4.

Simulation results summarized based on 5000 simulated trials under 9 fixed scenarios for each combination designs for finding multiple MTDs, including the product of independent beta probabilities escalation (PIPE) design24 and the waterfall design27. Four performance metrics are reported: (a) percentage of trials selecting at least one MTD; (b) percentage of trials selecting all MTDs; (c) percentage of patients allocated to the MTD; and (d) percentage of patients allocated to overdoses, where the overdose is defined as the dose combination that has a DLT probability greater than 33%. The percentage of selecting at least one overdose is provided in Figure S10 of Supplementary Materials.